PPARG and obesity due to melanocortin 4 receptor deficiency: A number of case-control studies demonstrated that obesity, insulin resistance/insufficient, metabolic syndrome and inflammation were correlative conditions in which PPARG could modify and regulate these actions, and influence the risk of cancer [10–12].